S1 BIOPHARMA
S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of sexual dysfunction in both women and men. The company’s development programs include first-in-class non-hormonal therapies designed to treat diminished sexual desire by restoring the natural balance of key neurotransmitters in the brain. The company’s lead product candidate, Lorexys, is currently positioned to advance to a Phase 2b clinical trial for the treatment of hypoactive sexual desire disorder (HSDD) in women. S1 Biopharma is evaluating partnerships, collaborations and out-licensing deals that will enable the company to rapidly advance its sexual dysfunction franchise as well as to accelerate the path to commercialization for its drug candidates in the U.S. and internationally.
S1 BIOPHARMA
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.s1biopharma.com
Total Employee:
1+
Status:
Active
Contact:
201-839-0941
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content Euro WordPress 6.0 Gravatar Profiles
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Shifa Biomedical
Shifa Biomedical is a drug discovery company that develops drugs for the treatment of cardiovascular disease.
Stromatis Pharma
Stromatis Pharma is developing a secreted frizzle-related protein 2 (sFRP2) antagonist for reverting stromal stellate cells.
Stock Details
Official Site Inspections
http://www.s1biopharma.com
- Host name: lax1.lugosoft.com
- IP address: 208.87.242.47
- Location: Walnut United States
- Latitude: 34.0233
- Longitude: -117.8512
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 91789
More informations about "S1 Biopharma"
ABOUT US - S1 Biopharma
S1 Biopharma, Inc. 7 World Trade Center 250 Greenwich St. 46th Floor New York City, NY 10007 Email: [email protected]@s1biopharma.comSee details»
S1 Biopharma - Crunchbase Company Profile & Funding
S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of sexual dysfunction in both women and men. The company’s development programs include …See details»
MANAGEMENT - S1 Biopharma
S1 Biopharma 2025 Company Profile: Valuation, …
Www.s1biopharma.com. Formerly Known As. S1 Pharmaceuticals. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. …See details»
S1 Biopharma Company Profile | Management and Employees List
Www.s1biopharma.com S1 Biopharma Profile and History S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company developing treatments for sexual dysfunction in both women and …See details»
S1 Biopharma - Org Chart, Teams, Culture & Jobs - The Org
View S1 Biopharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
S1 Biopharma, Inc. Company Profile | New York, NY | Competitors ...
Find company research, competitor information, contact details & financial data for S1 Biopharma, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
S1 Biopharma | Jersey City, NJ, USA Startup - gust.com
Website s1biopharma.com; Company Summary S1 Biopharma is a market‐focused company specializing in the discovery, development, and commercialization of drug therapies for …See details»
S1 BioPharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Www.s1biopharma.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. Other …See details»
S1 Biopharma - LinkedIn
Founded in 2008, S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction and hypoactive sexual desire disorder (HSDD) in both women and men. The company’s non ...See details»
S1 Biopharma, Inc. in New York, NY - (201) 839-0941 - Company …
S1 Biopharma, Inc. is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
BOARD OF DIRECTORS - S1 Biopharma
Prior to joining NuPathe Inc., Ms. Hollingsworth served as Executive Vice President and was a co-founder of Auxilium Pharmaceuticals Inc., a publicly traded biopharmaceutical company, and …See details»
S1 Biopharma - Craft
S1 Biopharma is a company developing drugs for the treatment of sexual dysfunction in both women and men. Its non-hormonal therapies act on the sexual centers of the brain by …See details»
Working at S1 Biopharma - Glassdoor
Glassdoor gives you an inside look at what it's like to work at S1 Biopharma, including salaries, reviews, office photos, and more. This is the S1 Biopharma company profile.See details»
S1 Biopharma - Overview, News & Similar companies - ZoomInfo
Mar 1, 2021 S1 Biopharma contact info: Phone number: (201) 839-0941 Website: www.s1biopharma.com What does S1 Biopharma do? S1 Biopharma, Inc. is a clinical-stage …See details»
S1 Biopharma - VentureRadar
Website: http://s1biopharma.com/ S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men.See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»
PRESS RELEASES - S1 Biopharma
March 4, 2021 S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group LLC Review of Late Stage Innovations in Women’s Health; December 1, 2019 Dose-Finding Study of Lorexys …See details»
PIPELINE - S1 Biopharma
S1 Biopharma, Inc. 7 World Trade Center 250 Greenwich St. 46th Floor New York City, NY 10007 Email: [email protected]@s1biopharma.comSee details»
NEWSROOM - S1 Biopharma
Feb 19, 2016 Visit the post for more. March 4, 2021 S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group LLC Review of Late Stage Innovations in Women’s Health; …See details»